Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Kite Pharma
Kite Pharma
Could Toxicity Issues Topple CAR-T Cancer Therapies?
Motley Fool
Sun, 08/28/16 - 10:09 am
CAR-T
clinical trials
Juno Therapeutics
Kite Pharma
Bluebird Bio
Ziopharma Oncology
Thumbs Up/Thumbs Down: The FDA backs another R&D scheme, Kite shows its speed while Eli Lilly and Astra stumble again
Endpoints
Fri, 08/12/16 - 11:05 am
FDA
R&D
Kite Pharma
AstraZeneca
Marathon Pharma
Eli Lilly
Kite grabs a stem cell biology ‘breakthrough’ in race for off-the-shelf T cell therapies
Endpoints
Tue, 07/26/16 - 11:01 am
Kite Pharma
CAR-T
drug development
Six Major Biotech Acquisitions You Could See in 2016 (Part 1 of 3)
Forbes
Thu, 07/21/16 - 09:29 am
biotech
M&A
Merck
Gilead Sciences
Kite Pharma
Medivation
Kite Pharma’s CAR-T Clinical Trial To Use Chemotherapy Drug Implicated In Patient Deaths
Xtalks
Fri, 07/15/16 - 10:18 am
Kite Pharma
clinical trials
CAR-T
chemotherapy
Juno Therapeutics
Kite Pharma opens cell therapy plant as lead CAR-T candidate gathers steam
BioPharma Dive
Tue, 06/21/16 - 11:17 pm
Kite Pharma
CAR-T
KTE-C19
Biotech Buzz: ASCO Winners and Losers and Biogen's Discouraging Failure
Motley Fool
Fri, 06/10/16 - 04:16 pm
biotech
ASCO 2016
Biogen
Immunomedics
AbbVie
Juno Therapeutics
Kite Pharma
3 Biotechs Expecting Market-Moving Trial Results Soon
Motley Fool
Mon, 06/6/16 - 11:07 am
biotech
Ophthotech
Achillion
Kite Pharma
odalasvir
JNJ
Fovista
KTE-C19
Kite Pharma rides CAR-T momentum into ASCO
BioPharma Dive
Fri, 06/3/16 - 09:46 pm
ASCO 2016
Kite Pharma
CAR-T
Kite Pharma Announces Review of National Cancer Institute’s Manufacturing Facilities
Yahoo
Sun, 04/17/16 - 10:42 am
Kite Pharma
National Cancer Institute
KTE-C19
clinical trials
3 Biotech Takeover Targets That Could Get Bought Soon
Motley Fool
Wed, 04/13/16 - 10:32 pm
biotech
M&A
Kite Pharma
Portola Pharmaceuticals
Medivation
This Could Be the Next Big Pharma Buyout
Motley Fool
Sun, 04/3/16 - 10:56 am
Big Pharma
M&A
JNJ
Geron
Acadia
Jazz Pharmaceuticals
Bluebird Bio
Kite Pharma
Roche, Kite Pharma sign CAR-T and PD-L1 combo deal
Fierce Biotech
Fri, 03/18/16 - 11:00 am
Roche
Kite Pharma
CAR-T
PD-L1
atezolizumab
KTE-C19
Kite, Juno ramping up commercial manufacturing capacity for CAR-T
BioPharma Dive
Sat, 03/5/16 - 10:03 am
Kite Pharma
Juno Therapeutics
drug manufacturing
CAR-T
Kite Pharma's CEO On Cancer-Killing T-Cells: 'This Is A Revolution'
Forbes
Fri, 02/26/16 - 09:36 am
Kite Pharma
cancer
CAR-T
Juno, Kite Valuations at Risk From Simpler T-Cell Cancer Therapy
TheStreet.com
Tue, 01/26/16 - 12:34 pm
Juno Therapeutics
Kite Pharma
CAR-T
Pfizer CEO: Our CAR-T development method could give us a leg up over Kite, Juno, Novartis
BioPharma Dive
Thu, 01/14/16 - 08:54 pm
Pfizer
Pharma CEOs
Ian Read
R&D
CAR-T
Novartis
Juno Therapeutics
Kite Pharma
Kite Pharma Leads IBB’s Mid-Caps on Its Zuma-1 Phase 1 Results
Yahoo/Market Realist
Wed, 12/9/15 - 11:40 am
Kite Pharma
Zuma-1
clinical trials
Successful trials not all Juno needs to get cancer treatment to market
Bizjournals.com
Fri, 10/30/15 - 04:01 pm
Juno Therapeutics
cancer immunotherapy
Novartis
Kite Pharma
Which Big Pharma Will Grab the Lion’s Share of the Cancer Immunotherapy Market?
Motley Fool
Wed, 09/30/15 - 07:59 pm
cancer immunotherapy
Juno Therapeutics
Kite Pharma
Celgene
Bluebird Bio
AstraZeneca
Pfizer
Bristol-Myers Squibb
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »